Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-22

Clinical Trial Update: A Study of LY2216684 and Digoxin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update on LY2216684 and digoxin in healthy subjects for Major Depressive Disorder; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)
  • LY2216684

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-22